Evidence map›Paper›PMID 29022005›Full record

ArticleCellular and molecular gastroenterology and hepatology2017

Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans.

Jayaum S Booth, Seema A Patil, Leyla Ghazi, Robin Barnes, Claire M Fraser, Alessio Fasano, Bruce D Greenwald, Marcelo B Sztein

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Developing Antiviral Vaccines Based on AttenuatedPathogens (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Association betweenHuman vaccines & immunotherapeutics · 2019
    Article
  13. Location Matters in Defining T Cell-mediated Immunity in Response toCellular and molecular gastroenterology and hepatology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jayaum S BoothCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.
Seema A PatilDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Leyla GhaziDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Robin BarnesCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.
Claire M FraserDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Alessio FasanoMucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, Massachusetts.
Bruce D GreenwaldDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Marcelo B SzteinCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.
University of Maryland, Baltimore · USMassachusetts General Hospital · US

Funding

Wild-type S. typhi Infection in Humans: Integrated Immunoprotective MechanismsU19AI082655 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI FRASER, CLAIRE M. · 2009 to 2018
$27.8M
Shigella Live Vector-Based Multivalent VaccineU19AI109776 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2014 to 2018
$25.4M
IMMUNE MECHANISMS OF PROTECTION IN S TYPHI VACCINESR01AI036525 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Marcelo B. Sztein · 1994 to 2026
$12.2M
NIAID NIH HHS R01 AI036525NIAID NIH HHS U19 AI082655NIAID NIH HHS U19 AI109776
6 · The paper itself

Abstract

BACKGROUND &

aimsSystemic cellular immunity elicited by the Ty21a oral typhoid vaccine has been extensively characterized. However, very limited data are available in humans regarding mucosal immunity at the site of infection (terminal ileum [TI]). Here we investigated the host immunity elicited by Ty21a immunization on terminal ileum-lamina propria mononuclear cells (LPMC) and peripheral blood in volunteers undergoing routine colonoscopy.

methodsWe characterized LPMC-T memory (T

resultsNo differences were observed in cell yields and phenotypes in LPMC CD8

conclusionsThis study provides the first demonstration of

Indexed as

CD8+-T Memory CellsCMI, cell-mediated immune responsesEBV-B, Epstein-Barr virus–transformed lymphoblastoid B cellsIFN, interferonIL, interleukinLamina Propria Mononuclear CellsLPMC, lamina propria mononuclear cellsMF, multifunctionalMIP, macrophage inflammatory proteinMultifunctional T CellsPBMC, peripheral blood mononuclear cellsS, S Typhi–specific single producing cellsTCM, T-central/memory (CD62L+CD45RA-)TEMRA, TEM-CD45RA+ (CD62L-CD45RA+)TEM, T-effector/memory (CD62L-CD45RA-)TI, terminal ileumTM, CD8+ T memoryTNF, tumor necrosis factorTyphoidVaccineswt, wild-type

Identifiers

PMID29022005
PMCPMC5626924
OpenAlexW2749359035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.